ANRO vs AMGN: Which Stock is Better?
Side-by-side comparison of Alto Neuroscience Inc and Amgen Inc in 2026
ANRO
Alto Neuroscience Inc
$21.99
AMGN
Amgen Inc
$369.53
Key Metrics Comparison
| Metric | ANRO | AMGN | Winner |
|---|---|---|---|
| Market Cap | $644.94M | $199.20B | AMGN |
| P/E Ratio | N/A | 25.97 | AMGN |
| EPS (TTM) | $N/A | $14.23 | AMGN |
| Revenue Growth | 0.0% | 0.1% | AMGN |
| Gross Margin | 0.0% | 70.8% | AMGN |
Analyze ANRO
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ANRO or AMGN a better investment?
Comparing ANRO and AMGN: Alto Neuroscience Inc has a market cap of $644.94M while Amgen Inc has $199.20B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ANRO and AMGN?
ANRO (Alto Neuroscience Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ANRO or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ANRO or AMGN?
AMGN has higher revenue growth at 0.1% vs 0.0% for ANRO.
Which company is more profitable: ANRO or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for ANRO.
Which is the larger company: ANRO or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $199.20B compared to $644.94M for ANRO.
Should I buy ANRO or AMGN in 2026?
Both ANRO and AMGN have investment merit. ANRO trades at $21.99 while AMGN trades at $369.53. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ANRO and AMGN stock?
Key differences: Market Cap ($644.94M vs $199.20B), P/E Ratio (N/A vs 26.0x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).